Literature DB >> 21833762

In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate.

Evren Gundogdu1, V Mangas-Sanjuan, Isabel Gonzalez-Alvarez, Marival Bermejo, Ercument Karasulu.   

Abstract

The purpose of this study was to estimate passive permeability and efflux transport parameters of fexofenadine (FEX) from in vitro cell culture and in situ rat experiments and determine the dissolution profile of FEX in the absence and presence of sodium dodecyl sulfate (SDS). The dissolution rate of FEX was investigated at different pH values and in the presence of SDS. The permeability of FEX was determined in situ in small intestine of Wistar rats and in vitro in Caco-2 cell monolayer. Permeability of FEX was determined at different donor concentrations, and the effect of SDS at two concentration levels (10 and 50 μM) on FEX permeability was evaluated. The transepithelial electrical resistance values of the in vitro technique were measured to assess monolayer integrity before and after the permeability studies. The FEX permeability parameters in the absence and presence of SDS were estimated using Phoenix WinNonlin software program and compared with other laboratory results for both in vitro and in situ studies. The results showed that FEX has a low permeability in the paracellular permeability as well a potential inhibition of secretion mediated by P-glycoprotein (P(gp)), and its permeability increased with presence of SDS. The dissolution of FEX was pH-dependent and significantly enhanced, especially in the presence of 50 mg SDS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21833762     DOI: 10.1007/s13318-011-0059-4

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  32 in total

1.  Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.

Authors:  F Damian; N Blaton; L Naesens; J Balzarini; R Kinget; P Augustijns; G Van den Mooter
Journal:  Eur J Pharm Sci       Date:  2000       Impact factor: 4.384

Review 2.  Permeability issues in nasal drug delivery.

Authors:  Priyanka Arora; Shringi Sharma; Sanjay Garg
Journal:  Drug Discov Today       Date:  2002-09-15       Impact factor: 7.851

Review 3.  Nasal route and drug delivery systems.

Authors:  Selcan Türker; Erten Onur; Yekta Ozer
Journal:  Pharm World Sci       Date:  2004-06

4.  Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by caco-2 monolayers.

Authors:  Andrea Weissenboeck; Elisabeth Bogner; Michael Wirth; Franz Gabor
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

5.  Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM.

Authors:  I González-Alvarez; C Fernández-Teruel; T M Garrigues; V G Casabo; A Ruiz-García; M Bermejo
Journal:  Xenobiotica       Date:  2005-12       Impact factor: 1.908

6.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

7.  Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics.

Authors:  E Biganzoli; L A Cavenaghi; R Rossi; M C Brunati; M L Nolli
Journal:  Farmaco       Date:  1999-09-30

8.  Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route.

Authors:  E K Anderberg; T Lindmark; P Artursson
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

9.  A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.

Authors:  Erin D Hugger; Barbara L Novak; Philip S Burton; Kenneth L Audus; Ronald T Borchardt
Journal:  J Pharm Sci       Date:  2002-09       Impact factor: 3.534

10.  Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat.

Authors:  Arik Dahan; Brady T West; Gordon L Amidon
Journal:  Eur J Pharm Sci       Date:  2008-11-05       Impact factor: 4.384

View more
  5 in total

1.  "Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development Strategy.

Authors:  Bart Hens; Maura Corsetti; Marival Bermejo; Raimar Löbenberg; Pablo M González; Amitava Mitra; Divyakant Desai; Dakshina Murthy Chilukuri; Alexis Aceituno
Journal:  AAPS J       Date:  2019-06-06       Impact factor: 4.009

2.  Evaluating the Anti-nociceptive and Anti-inflammatory Effects of Ketotifen and Fexofenadine in Rats.

Authors:  Mahdieh Anoush; Mohammad Reza Mohammad Khani
Journal:  Adv Pharm Bull       Date:  2015-06-01

3.  Solid Form and Phase Transformation Properties of Fexofenadine Hydrochloride during Wet Granulation Process.

Authors:  Suye Li; Hengqian Wu; Yanna Zhao; Ruiyan Zhang; Zhengping Wang; Jun Han
Journal:  Pharmaceutics       Date:  2021-05-27       Impact factor: 6.321

Review 4.  Drug transport mechanism of oral antidiabetic nanomedicines.

Authors:  Evren Gundogdu; Aysu Yurdasiper
Journal:  Int J Endocrinol Metab       Date:  2014-01-01

5.  Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products.

Authors:  Alejandro Ruiz-Picazo; Sarin Colón-Useche; Blanca Perez-Amorós; Marta González-Álvarez; Irene Molina-Martínez; Isabel González-Álvarez; Alfredo García-Arieta; Marival Bermejo
Journal:  Pharmaceutics       Date:  2019-12-09       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.